BioSpace News Archive

Complete portfolio of all commonly used sizes and strengths of Adenosine Injection, USP now available from Fresenius Kabi

A facility for multidisciplinary research to benefit human and animal health in the Caribbean

Canopy Growth Corporation and Hiku Brands Company Ltd. are pleased to announce that they have entered into a definitive arrangement agreement (the “Agreement”) pursuant to which Canopy Growth will acquire all of the issued and outstanding common shares of Hiku (the “Transaction”).

The U.S. Food and Drug Administration today is requiring safety labeling changes for a class of antibiotics called fluoroquinolones

Ultivue has announced the public launch of its UltiMapper™ portfolio of reagents enabling the highest throughput of whole-slide, protein biomarker analysis and spatial detection in tissue, at high level of multiplexing, using instrumentation and software solutions currently found in most Immuno-Histochemistry laboratories.

Update to list of affected products

Conference Call and Webcast Scheduled for Tuesday, July 31

Natera, Inc. announced the launch of a proposed follow-on public offering of $75,000,000 of shares of its common stock.

Record quarter as revenues grow 26.7%, 9MoFY18 net income up 63.8%

SRI International announced a research agreement with Ionis Pharmaceuticals, combining SRI’s proprietary FOX Three Molecular Guidance cellular targeting system (MGS) with Ionis’ proprietary antisense drug-discovery platform.